{"id":"duration-of-treatment-3-months","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Hot flashes"},{"rate":"5-10%","effect":"Vaginal discharge"},{"rate":"5-10%","effect":"Headache"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"The drug targets a key enzyme involved in the disease process, thereby reducing the symptoms and slowing disease progression.","oneSentence":"This drug works by inhibiting the activity of a specific enzyme.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:10:18.232Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Treatment of endometriosis"},{"name":"Treatment of uterine fibroids"}]},"trialDetails":[{"nctId":"NCT04943224","phase":"PHASE2","title":"Optimization of the Time and Dosage of Trametinib in BRAF Negative Juvenile Patients","status":"RECRUITING","sponsor":"Anna Raciborska","startDate":"2021-04-01","conditions":"Histiocytosis","enrollment":12},{"nctId":"NCT03364114","phase":"NA","title":"Endorotor Resection In Refractory Barrett's Dysplasia Patients","status":"TERMINATED","sponsor":"Interscope, Inc.","startDate":"2018-02-09","conditions":"Barrett's Esophagus With Dysplasia","enrollment":15},{"nctId":"NCT05564377","phase":"PHASE2","title":"Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2023-04-07","conditions":"Advanced Malignant Solid Neoplasm, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8","enrollment":2900},{"nctId":"NCT06902246","phase":"PHASE2","title":"Regorafenib and Yttrium-90 Radioembolization for Unresectable Hepatocellular Carcinoma","status":"RECRUITING","sponsor":"University of Miami","startDate":"2026-05-01","conditions":"Unresectable Hepatocellular Carcinoma, Hepatocellular Carcinoma","enrollment":30},{"nctId":"NCT05131022","phase":"PHASE1","title":"A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies","status":"RECRUITING","sponsor":"Nurix Therapeutics, Inc.","startDate":"2022-04-13","conditions":"Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL), Diffuse Large B Cell Lymphoma (DLBCL)","enrollment":572},{"nctId":"NCT05826509","phase":"PHASE2","title":"SUrGery With or Without dARolutamide in High-risk and/or Locally Advanced Prostate Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"Institut Claudius Regaud","startDate":"2023-08-10","conditions":"Prostate Cancer","enrollment":240},{"nctId":"NCT07486037","phase":"NA","title":"Caring for Caregivers","status":"RECRUITING","sponsor":"Indiana University","startDate":"2026-03-01","conditions":"Intervention Group, Treatment as Usual","enrollment":25},{"nctId":"NCT07498387","phase":"NA","title":"Management of Catatonic Features in Adolescents With Profound Autism","status":"ACTIVE_NOT_RECRUITING","sponsor":"Tanta University","startDate":"2026-01-01","conditions":"Autism Spectrum Disorder, Catatonia","enrollment":30},{"nctId":"NCT02275533","phase":"PHASE2","title":"Testing Nivolumab to Prevent Disease From Coming Back After Treatment in Patients With Acute Myeloid Leukemia, REMAIN Trial","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2015-07-02","conditions":"Acute Myeloid Leukemia","enrollment":82},{"nctId":"NCT03919071","phase":"PHASE2","title":"Dabrafenib Combined With Trametinib After Radiation Therapy in Treating Patients With Newly-Diagnosed High-Grade Glioma","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2020-02-20","conditions":"Anaplastic Astrocytoma, Anaplastic Astrocytoma, Not Otherwise Specified, Anaplastic Ganglioglioma","enrollment":58},{"nctId":"NCT04466488","phase":"NA","title":"Prevent TB: Choice Architecture for TPT Delivery","status":"COMPLETED","sponsor":"Johns Hopkins University","startDate":"2021-09-15","conditions":"HIV/AIDS, Tuberculosis","enrollment":50798},{"nctId":"NCT07458100","phase":"NA","title":"The STEP-MIED Trial: Digital Stepped-Care for Emotional Disorders","status":"RECRUITING","sponsor":"Peking University","startDate":"2026-03","conditions":"Emotional Disorders, Depressive Disorder, Anxiety Disorders","enrollment":464},{"nctId":"NCT05788744","phase":"NA","title":"Implementing ctDNA and Circular DNA in Patients With Localized Pancreatic Cancer","status":"RECRUITING","sponsor":"Copenhagen University Hospital at Herlev","startDate":"2023-01-01","conditions":"Resectable Pancreatic Cancer","enrollment":1000},{"nctId":"NCT07127458","phase":"NA","title":"Anxiety and Depression in Adolescent PCOS","status":"COMPLETED","sponsor":"Ege University","startDate":"2025-08-17","conditions":"PCOS (Polycystic Ovary Syndrome)","enrollment":42},{"nctId":"NCT07492238","phase":"NA","title":"Plasma Multi - Omics Detection for Evaluating Efficacy and Recurrence Risk in Oligometastatic Colorectal Cancer Conversion Therapy","status":"ACTIVE_NOT_RECRUITING","sponsor":"Xiujuan Qu","startDate":"2025-03-20","conditions":"Colorectal Cancer","enrollment":120},{"nctId":"NCT06925724","phase":"PHASE2","title":"A Study of Ivonescimab in People With Endometrial and Cervical Cancers","status":"RECRUITING","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2025-04-04","conditions":"Endometrial Cancer, Cervical Cancer","enrollment":50},{"nctId":"NCT07123090","phase":"PHASE2","title":"A Study of Sasanlimab, Palbociclib and Axitinib in Metastatic Renal Cell Carcinoma","status":"RECRUITING","sponsor":"Stephanie Berg","startDate":"2025-11-24","conditions":"Metastatic Renal Cell Carcinoma, Metastatic Renal Cancer, Renal Cell Carcinoma","enrollment":25},{"nctId":"NCT07490964","phase":"","title":"Polycystic Ovary Syndrome in Type 1 Diabetes","status":"NOT_YET_RECRUITING","sponsor":"Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal","startDate":"2026-04-01","conditions":"Type 1 Diabetes Mellitus, Polycystic Ovary Syndrome (PCOS)","enrollment":60},{"nctId":"NCT07003919","phase":"PHASE3","title":"Safety Study of Viaskin® Peanut Patch in Peanut-Allergic Children 1 Through 3 Years of Age (COMFORT Toddlers)","status":"RECRUITING","sponsor":"DBV Technologies","startDate":"2025-06-24","conditions":"Allergy, Peanut Allergy","enrollment":480},{"nctId":"NCT05410132","phase":"NA","title":"Internet-based Mindfulness-based Training (iMBT) for People With Depression","status":"COMPLETED","sponsor":"Chinese University of Hong Kong","startDate":"2022-03-24","conditions":"Mindfulness, Depression","enrollment":116},{"nctId":"NCT05212272","phase":"NA","title":"MRI in High-Grade Glioma Patients Undergoing Chemoradiation","status":"RECRUITING","sponsor":"Wake Forest University Health Sciences","startDate":"2022-09-02","conditions":"High Grade Glioma","enrollment":16},{"nctId":"NCT03753659","phase":"PHASE2","title":"IMMULAB - Immunotherapy With Pembrolizumab in Combination With Local Ablation in Hepatocellular Carcinoma (HCC)","status":"COMPLETED","sponsor":"Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest","startDate":"2019-05-09","conditions":"Hepatocellular Carcinoma (HCC)","enrollment":30},{"nctId":"NCT07488494","phase":"NA","title":"Effective Implementation of the Physical Activity and Motor Skills Intervention for 3-6-year-old Children With Cancer (EMPOWER)","status":"NOT_YET_RECRUITING","sponsor":"Turku University Hospital","startDate":"2026-03-01","conditions":"Physical Activity During Cancer Treatment","enrollment":40},{"nctId":"NCT07001748","phase":"PHASE2, PHASE3","title":"Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavity","status":"RECRUITING","sponsor":"ECOG-ACRIN Cancer Research Group","startDate":"2025-08-19","conditions":"Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma, Peritoneal Carcinomatosis","enrollment":148},{"nctId":"NCT07005102","phase":"PHASE2, PHASE3","title":"A Study to Assess Adverse Events, Change in Disease Activity of Intravenous Telisotuzumab Adizutecan in Combination With Osimertinib as First-Line Treatment in Adult Participants With Locally Advanced Unresectable or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer","status":"RECRUITING","sponsor":"AbbVie","startDate":"2025-08-03","conditions":"Non-Squamous Non-Small Cell Lung Cancer","enrollment":854},{"nctId":"NCT06516146","phase":"NA","title":"Impact 360 for Healthy Agers","status":"RECRUITING","sponsor":"University of British Columbia","startDate":"2024-01-24","conditions":"Healthy Aging","enrollment":60},{"nctId":"NCT07320963","phase":"PHASE1, PHASE2","title":"Chidamide in Combination With Toripalimab and Anlotinib in Recurrent/Metastatic Nasopharyngeal Carcinoma.","status":"NOT_YET_RECRUITING","sponsor":"Sun Yat-sen University","startDate":"2026-03-31","conditions":"Nasopharyngeal Carcinoma","enrollment":52},{"nctId":"NCT07484711","phase":"NA","title":"F.I.R.E.- Fighters With Focus, Intention, Regulation and Engagement","status":"NOT_YET_RECRUITING","sponsor":"University of Coimbra","startDate":"2026-08","conditions":"Firefighters' Mental Health","enrollment":53},{"nctId":"NCT07485010","phase":"PHASE2","title":"Testing a Novel Combination Treatment (Arm D) Versus Standard of Care for Intensive Phase Treatment for Mycobacterium Abscessus Pulmonary Disease in People With or Without Cystic Fibrosis in the Finding the Optimal Regimen for Mycobacterium Abscessus Treatment (FORMaT) Adaptive Platform Trial","status":"NOT_YET_RECRUITING","sponsor":"The University of Queensland","startDate":"2027-04","conditions":"Mycobacterium Abscessus Pulmonary Disease, Mycobacterium Abscessus Infection, Non-Tuberculous Mycobacterial (NTM) Infections","enrollment":300},{"nctId":"NCT07485335","phase":"PHASE4","title":"A Bundled Intervention - Phase 2","status":"NOT_YET_RECRUITING","sponsor":"University of Alabama at Birmingham","startDate":"2026-09-07","conditions":"Opioid Use Disorder, Opioid Overdose","enrollment":160},{"nctId":"NCT07484919","phase":"NA","title":"Virtual Reality Intervention (VR-GINSO) for Reducing Aggression in Young Offenders","status":"RECRUITING","sponsor":"Universidad Francisco de Vitoria","startDate":"2025-12-15","conditions":"Aggression","enrollment":110},{"nctId":"NCT06881134","phase":"NA","title":"Rehabilitation Combining Spatiotemporal Spinal Cord Stimulation and Real-time Triggering Exoskeleton After Spinal Cord Injury","status":"COMPLETED","sponsor":"Xuanwu Hospital, Beijing","startDate":"2024-10-13","conditions":"Spinal Cord Injury, Neuromodulation, Robot Assisted Gait Training","enrollment":10},{"nctId":"NCT06133062","phase":"PHASE2","title":"Atezolizumab and Bevacizumab With Proton Radiotherapy for Unresectable Hepatocellular Carcinoma","status":"RECRUITING","sponsor":"Chang Gung Memorial Hospital","startDate":"2023-11-16","conditions":"Hepatocellular Carcinoma Non-resectable","enrollment":45},{"nctId":"NCT05235061","phase":"NA","title":"HOme-Based Self-management and COgnitive Training CHanges Lives (HOBSCOTCH) -Post-Traumatic Epilepsy (PTE)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Dartmouth-Hitchcock Medical Center","startDate":"2022-03-21","conditions":"Epilepsy, Traumatic, Brain Injuries, Traumatic","enrollment":160},{"nctId":"NCT07398677","phase":"NA","title":"SchoolCare: A Social Intervention Introducing Telepresence Robots and School Navigation to Reduce School Fragmentation for Children Undergoing Cancer Treatment","status":"RECRUITING","sponsor":"Rigshospitalet, Denmark","startDate":"2026-02-20","conditions":"School Attendance, Academic Level, Childhood Cancer Survivors","enrollment":128},{"nctId":"NCT07141615","phase":"NA","title":"Clinical Observation of Qingwei Huazhuo Decoction (Product: Jinsaiyu) in Improving Children With Precocious Puberty of Phlegm-Dampness Internal Accumulation Type","status":"NOT_YET_RECRUITING","sponsor":"Children's Hospital of Fudan University","startDate":"2026-03-30","conditions":"Precocious Puberty","enrollment":94},{"nctId":"NCT05994742","phase":"PHASE3","title":"An Adaptive Multi-arm Trial to Improve Clinical Outcomes Among Children Recovering From Complicated SAM","status":"ACTIVE_NOT_RECRUITING","sponsor":"Queen Mary University of London","startDate":"2024-07-15","conditions":"Severe Acute Malnutrition, HIV, Comorbidities and Coexisting Conditions","enrollment":674},{"nctId":"NCT06562881","phase":"NA","title":"Patient Navigation to Improve Surgical Access in Primary Hyperparathyroidism","status":"RECRUITING","sponsor":"University of Pennsylvania","startDate":"2026-05-01","conditions":"Hyperparathyroidism, Primary","enrollment":76},{"nctId":"NCT06352710","phase":"","title":"Determining Postoperative Recovery and the Impact of Adverse Events in Neurosurgery Based on Self-reported, App-based Longitudinal Assessment","status":"RECRUITING","sponsor":"Cantonal Hospital of St. Gallen","startDate":"2023-06-12","conditions":"Disc Disease, Instabilities Lumbar, Brain Tumor","enrollment":400},{"nctId":"NCT07251751","phase":"NA","title":"Forward Versus Backward Gait Training on Functional Abilities in Children With Spastic Cerebral Palsy","status":"COMPLETED","sponsor":"Cairo University","startDate":"2025-11-01","conditions":"Spastic Cerebral Palsy","enrollment":60},{"nctId":"NCT04415944","phase":"PHASE2","title":"Trial Evaluating Feasibility and Quality of Life of Second Look Laparoscopy With Hyperthermic Intraperitoneal Chemotherapy","status":"COMPLETED","sponsor":"Wake Forest University Health Sciences","startDate":"2021-05-20","conditions":"Ovarian Epithelial Cancer Stage I, Ovarian Epithelial Cancer Stage II, Ovarian Epithelial Cancer Stage III","enrollment":10},{"nctId":"NCT05318196","phase":"","title":"Molecular Prediction of Development, Progression or Complications of Kidney, Immune or Transplantation-related Diseases","status":"RECRUITING","sponsor":"University Hospital, Toulouse","startDate":"2022-09-05","conditions":"Acute Kidney Injury, Chronic Kidney Diseases, Solid-organ Transplantation","enrollment":5000},{"nctId":"NCT05847478","phase":"NA","title":"Effects of Auricular Acupressure Versus Intermittent Dietary Restriction in Children With Gastric Heat and Dampness Obstruction","status":"RECRUITING","sponsor":"Children's Hospital of Fudan University","startDate":"2023-06-07","conditions":"Obesity, Childhood","enrollment":240},{"nctId":"NCT06910475","phase":"NA","title":"Physical Exercise and Biomolecular Analysis to Reduce Uremic Toxins in Chronic Kidney Disease: An Exploratory Study","status":"ENROLLING_BY_INVITATION","sponsor":"Catholic University of Brasília","startDate":"2025-04-01","conditions":"Kidney Disease, Chronic, Kidney Failure Chronic","enrollment":1600},{"nctId":"NCT07481149","phase":"PHASE3","title":"Trial of a Virtual Exercise-based Rehabilitation Program to Treat Persistent Chemotherapy-Induced Peripheral Neuropathy (CIPN)","status":"NOT_YET_RECRUITING","sponsor":"University Health Network, Toronto","startDate":"2026-03-30","conditions":"Chemotherapy-induced Peripheral Neuropathy (CIPN)","enrollment":240},{"nctId":"NCT07476235","phase":"","title":"Predictors of Treatment Response to Stellate Ganglion Block in Cervical Radicular Pain","status":"COMPLETED","sponsor":"Asan Medical Center","startDate":"2024-10-08","conditions":"Radiculopathy, Cervical Region","enrollment":90},{"nctId":"NCT03301220","phase":"PHASE3","title":"A Study of Subcutaneous Daratumumab Versus Active Monitoring in Participants With High-Risk Smoldering Multiple Myeloma","status":"ACTIVE_NOT_RECRUITING","sponsor":"Janssen Research & Development, LLC","startDate":"2017-11-07","conditions":"Smoldering Multiple Myeloma","enrollment":390},{"nctId":"NCT07060404","phase":"PHASE2, PHASE3","title":"Postpartum 8-aminoquinoline Breast Milk Study","status":"NOT_YET_RECRUITING","sponsor":"Curtin University","startDate":"2026-04","conditions":"Drug Pharmacokinetics in Healthy Volunteers","enrollment":60},{"nctId":"NCT07100496","phase":"PHASE4","title":"Evaluation of MIG-SPRAY Treatment on Migraine","status":"ACTIVE_NOT_RECRUITING","sponsor":"University Hospital, Clermont-Ferrand","startDate":"2025-09-15","conditions":"Migraine","enrollment":45},{"nctId":"NCT06884280","phase":"PHASE3","title":"Comparing High and Low Dose Iron Treatments for People on Peritoneal Dialysis: The PALaDIN Study","status":"RECRUITING","sponsor":"Hull University Teaching Hospitals NHS Trust","startDate":"2025-11-13","conditions":"Peritoneal Dialysis, Anaemia, Iron Deficiency, Anaemia","enrollment":30},{"nctId":"NCT06969833","phase":"NA","title":"Prospective Clinico-biological Database of Patients With Ovarian and/or Peritoneal and/or Fallopian Tube Carcinoma","status":"RECRUITING","sponsor":"Centre Oscar Lambret","startDate":"2025-06-27","conditions":"Cancer of the Ovary, Cancer of the Fallopian Tube, Peritoneal Cancer","enrollment":371},{"nctId":"NCT03462342","phase":"PHASE2","title":"Combination ATR and PARP Inhibitor (CAPRI) Trial With AZD6738 and Olaparib in Recurrent Ovarian Cancer","status":"COMPLETED","sponsor":"University of Pennsylvania","startDate":"2018-03-09","conditions":"High Grade Serous Carcinoma","enrollment":123},{"nctId":"NCT07188805","phase":"PHASE3","title":"A Study to Learn More About How Well Finerenone Works, How Safe it is, and How it Moves Into, Through, and Out of the Body Compared to Placebo When Taken With Standard Treatment in Children With Heart Failure and Left Ventricular Systolic Dysfunction","status":"RECRUITING","sponsor":"Bayer","startDate":"2025-11-19","conditions":"Left Ventricular Systolic Dysfunction, Heart Failure (Pediatric)","enrollment":111},{"nctId":"NCT07478705","phase":"NA","title":"Early Detection of Metastatic Recurrence Among Patients With Stage II or III Triple Negative Breast Cancer Using Liquid Biopsy and Imaging","status":"NOT_YET_RECRUITING","sponsor":"Sunnybrook Health Sciences Centre","startDate":"2026-05-01","conditions":"Triple Negative Breast Cancer, Surveillance, Recurrence","enrollment":30},{"nctId":"NCT06859424","phase":"PHASE2","title":"A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation","status":"RECRUITING","sponsor":"Center for International Blood and Marrow Transplant Research","startDate":"2025-07-25","conditions":"AML (Acute Myelogenous Leukemia), Acute Lymphoid Leukemia (ALL), Acute Leukemia (Category)","enrollment":358},{"nctId":"NCT05794906","phase":"PHASE3","title":"A Study to Compare Darolutamide Given With Androgen Deprivation Therapy (ADT) and Placebo Given With ADT in Men With Hormone Sensitive Prostate Cancer and Raise of Prostate Specific Antigen (PSA) Levels After Local Therapies","status":"ACTIVE_NOT_RECRUITING","sponsor":"Bayer","startDate":"2023-04-03","conditions":"Biochemically Recurrent Prostate Cancer","enrollment":985},{"nctId":"NCT04943848","phase":"PHASE1","title":"rHSC-DIPGVax Plus Checkpoint Blockade for the Treatment of Newly Diagnosed DIPG and DMG","status":"RECRUITING","sponsor":"Ann & Robert H Lurie Children's Hospital of Chicago","startDate":"2022-01-10","conditions":"Diffuse Intrinsic Pontine Glioma, Diffuse Midline Glioma, H3 K27M-Mutant","enrollment":36},{"nctId":"NCT07478029","phase":"","title":"Clinical Study of PEG Bowel Preparation in Appendectomy Patients","status":"RECRUITING","sponsor":"Huaping Xie","startDate":"2024-02-23","conditions":"Appendicitis, Appendicitis Acute","enrollment":10},{"nctId":"NCT06840834","phase":"PHASE2","title":"Evaluating Ivonescimab as a Potential Treatment for Pleural Mesothelioma Patients Whose Cancer Has Returned After Previous Immunotherapy and Chemotherapy","status":"RECRUITING","sponsor":"Intergroupe Francophone de Cancerologie Thoracique","startDate":"2025-06-30","conditions":"Pleural Mesotheliomas","enrollment":38},{"nctId":"NCT06510764","phase":"PHASE3","title":"A Trial of Chinese Traditional Medicine Combining With Intradermal Acupuncture for Treating Precocious Puberty","status":"RECRUITING","sponsor":"Children's Hospital of Fudan University","startDate":"2024-09-15","conditions":"Precocious Puberty, Treatment, Alternative Medicine","enrollment":170},{"nctId":"NCT03547973","phase":"PHASE2","title":"Study of Sacituzumab Govitecan in Participants With Urothelial Cancer That Cannot Be Removed or Has Spread","status":"RECRUITING","sponsor":"Gilead Sciences","startDate":"2018-08-13","conditions":"Metastatic Urothelial Cancer","enrollment":827},{"nctId":"NCT07344142","phase":"NA","title":"Improving Digital Wellbeing in Saudi Adolescents","status":"RECRUITING","sponsor":"Johns Hopkins Bloomberg School of Public Health","startDate":"2026-01-25","conditions":"Digital Technology Use, Social Media Addiction, Internet Gaming Disorder","enrollment":2500},{"nctId":"NCT06595732","phase":"NA","title":"Contin-RUN Study: Urinary Incontinence in Female Runners","status":"COMPLETED","sponsor":"Federal University of Uberlandia","startDate":"2024-09-20","conditions":"Urinary Incontinence","enrollment":120},{"nctId":"NCT06075953","phase":"PHASE2","title":"DCIS: RECAST Trial Ductal Carcinoma In Situ: Re-Evaluating Conditions for Active Surveillance Suitability as Treatment","status":"RECRUITING","sponsor":"QuantumLeap Healthcare Collaborative","startDate":"2024-02-17","conditions":"Ductal Carcinoma in Situ","enrollment":400},{"nctId":"NCT06876233","phase":"NA","title":"Mobile Cued Adherence Therapy (mCAT) for Blood Pressure Medication","status":"RECRUITING","sponsor":"Chad Stecher@asu.edu","startDate":"2025-09-01","conditions":"Medication Adherence, Hypertension, Habits","enrollment":600},{"nctId":"NCT04961580","phase":"","title":"PK/PD of Ceftazidime Avitbatan Sodium in Children With Severe Infection","status":"RECRUITING","sponsor":"Children's Hospital of Fudan University","startDate":"2022-10-01","conditions":"Sepsis, Antibiotic Reaction","enrollment":30},{"nctId":"NCT06460220","phase":"NA","title":"SAFETY-Parent: Online Learning Module to Support Parents of Suicidal Youth","status":"ENROLLING_BY_INVITATION","sponsor":"Jennifer Hughes","startDate":"2024-06-10","conditions":"Suicide, Suicide, Attempted, Suicide and Self-harm","enrollment":65},{"nctId":"NCT07472868","phase":"PHASE3","title":"Neoadjuvant FOLFOXIRI and Chemoradiotherapy Versus Neoadjuvant CAPOX/FOLFOX and Chemoradiotherapy Followed by Surgery or a Watch-and-Wait Approach in High Risk Locally Advanced Rectal Cancer","status":"NOT_YET_RECRUITING","sponsor":"J. W. A. Burger","startDate":"2026-03-03","conditions":"Locally Advanced Rectal Carcinoma","enrollment":394},{"nctId":"NCT00107289","phase":"PHASE2","title":"Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma","status":"RECRUITING","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2006-05","conditions":"Neuroblastoma, Pheochromocytoma","enrollment":200},{"nctId":"NCT04936529","phase":"PHASE2","title":"A Study of a Vaccine in Combination With β-glucan and GM-CSF in People With Neuroblastoma","status":"RECRUITING","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2021-08-02","conditions":"Neuroblastoma","enrollment":286},{"nctId":"NCT00580515","phase":"NA","title":"Trial of Family Focused Grief Therapy in Palliative Care and Bereavement","status":"COMPLETED","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2005-11-08","conditions":"Cancer","enrollment":700},{"nctId":"NCT07319429","phase":"PHASE2, PHASE3","title":"Refining Fertility-sparing Treatment in Endometrial Carcinoma Based on Molecular Classification","status":"RECRUITING","sponsor":"Fudan University","startDate":"2026-01-25","conditions":"Endometrial Cancer, Fertility","enrollment":260},{"nctId":"NCT05639556","phase":"","title":"Strength and Muscle Related Outcomes for Nutrition and Lung Function in CF","status":"ACTIVE_NOT_RECRUITING","sponsor":"Jaeb Center for Health Research","startDate":"2023-04-20","conditions":"Cystic Fibrosis","enrollment":300},{"nctId":"NCT02287428","phase":"PHASE1","title":"Personalized NeoAntigen Cancer Vaccine w RT Plus Pembrolizumab for Patients With Newly Diagnosed GBM","status":"RECRUITING","sponsor":"Dana-Farber Cancer Institute","startDate":"2014-11","conditions":"Glioblastoma","enrollment":56},{"nctId":"NCT04293393","phase":"PHASE2","title":"Neoadjuvant Study Chemotherapy vs Letrozole + Abemaciclib in HR+/HER2- High/Intermediate Risk Breast Cancer Patients","status":"ACTIVE_NOT_RECRUITING","sponsor":"Spanish Breast Cancer Research Group","startDate":"2020-10-02","conditions":"Early Breast Cancer","enrollment":200},{"nctId":"NCT07467967","phase":"NA","title":"Impact of Date Consumption on Metabolic Control and Oxidative Stress in Patients With Type 2 Diabetes","status":"NOT_YET_RECRUITING","sponsor":"University Tunis El Manar","startDate":"2026-07-15","conditions":"Diabete Type 2","enrollment":130},{"nctId":"NCT03477435","phase":"NA","title":"Comparing an Opt-out to an opt-in Approach for Smoking Cessation in VA Primary Care Clinics","status":"ACTIVE_NOT_RECRUITING","sponsor":"VA Office of Research and Development","startDate":"2019-08-28","conditions":"Tobacco Use","enrollment":1365},{"nctId":"NCT06134375","phase":"PHASE1, PHASE2","title":"A Study of Tetrathiomolybdate (TM) Plus Capecitabine","status":"RECRUITING","sponsor":"Dartmouth-Hitchcock Medical Center","startDate":"2024-11-26","conditions":"Triple Negative Breast Cancer, Residual Disease","enrollment":204},{"nctId":"NCT07013214","phase":"NA","title":"Rehabilitation With Dual-task Exercises to Improve Balance in Patients With Parkinson's Disease","status":"RECRUITING","sponsor":"G. d'Annunzio University","startDate":"2025-07-07","conditions":"Parkinson Disease (PD), Postural Balance","enrollment":74},{"nctId":"NCT01603316","phase":"PHASE2","title":"Food: A Three-Arm Study Examining Food Insecurity Interventions","status":"ACTIVE_NOT_RECRUITING","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2012-05-08","conditions":"Cancer Patients","enrollment":606},{"nctId":"NCT06909682","phase":"","title":"AI-Based Monitoring System for Chronic Heart Failure With Advanced Wearable and Mini-Invasive Devices","status":"RECRUITING","sponsor":"University of Salerno","startDate":"2025-08-01","conditions":"Chronic Heart Failure, Cardiovascular Diseases, Heart Failure With Reduced Ejection Fraction (HFrEF)","enrollment":205},{"nctId":"NCT07459777","phase":"NA","title":"Early arthroscoPic Stabilization veRsus rehabilitatiOn of the Shoulder in Adolescents With a trauMatic First-time Anterior Shoulder Dislocation ePisode.","status":"NOT_YET_RECRUITING","sponsor":"McMaster University","startDate":"2026-04-01","conditions":"Shoulder Dislocation","enrollment":30},{"nctId":"NCT05926024","phase":"","title":"Long-Term Follow-Up in Women With Early Breast Cancer Three Years of More Post Primary Treatment","status":"ACTIVE_NOT_RECRUITING","sponsor":"UNC Lineberger Comprehensive Cancer Center","startDate":"2023-01-06","conditions":"Breast Cancer","enrollment":253},{"nctId":"NCT02521311","phase":"PHASE2","title":"Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER)","status":"RECRUITING","sponsor":"University of California, San Francisco","startDate":"2017-02-28","conditions":"Optic Neuritis","enrollment":90},{"nctId":"NCT07155187","phase":"PHASE2, PHASE3","title":"A Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) Telisotuzumab Adizutecan Compared to Standard of Care in Adult Participants With Locally Advanced or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer","status":"RECRUITING","sponsor":"AbbVie","startDate":"2025-12-10","conditions":"Non-Small Cell Lung Cancer","enrollment":430},{"nctId":"NCT07460037","phase":"NA","title":"Chinese-Specific Speech Imagery Coding Using High-Density ECoG","status":"RECRUITING","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2026-03-15","conditions":"Aphasia, Dysarthria, ALS","enrollment":50},{"nctId":"NCT06838299","phase":"NA","title":"Two Different Renal Rehabilitation Protocols in Hemodialysis Patients","status":"COMPLETED","sponsor":"Beni-Suef University","startDate":"2025-02-28","conditions":"Hemodialysis","enrollment":90},{"nctId":"NCT02720874","phase":"NA","title":"Multidisciplinary Approach for Treat To Target In Rheumatoid Arthritis","status":"WITHDRAWN","sponsor":"Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center","startDate":"2025-01-01","conditions":"Arthritis, Rheumatoid","enrollment":""},{"nctId":"NCT05665348","phase":"PHASE2, PHASE3","title":"Study Evaluating the Benefit of Adding Ipilimumab to the Combination of Atezolizumab and Bevacizumab in Patients With Hepatocellular Carcinoma Receiving First-line Systemic Therapy","status":"COMPLETED","sponsor":"Federation Francophone de Cancerologie Digestive","startDate":"2023-03-09","conditions":"HCC - Hepatocellular Carcinoma, Metastatic Cancer, Metastatic Tumor","enrollment":229},{"nctId":"NCT02774759","phase":"NA","title":"Feasibility of the NEXT Steps Weight Loss Intervention +/- Resistance Training for Endometrial Cancer Survivors: Effect on Lean Mass & Biomarkers","status":"ACTIVE_NOT_RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2016-10-17","conditions":"Malignant Neoplasms of Female Genital Organs","enrollment":15},{"nctId":"NCT07140874","phase":"PHASE2","title":"Zinc as an Adjunctive Therapy for Cervical Dystonia","status":"RECRUITING","sponsor":"University of Florida","startDate":"2026-02-20","conditions":"Cervical Dystonia","enrollment":20},{"nctId":"NCT06647680","phase":"PHASE2","title":"Neoadjuvant Chemotherapy and PD-1 Inhibitor for Locally Advanced Rectal Cancer（CONTROL-01）","status":"RECRUITING","sponsor":"The Affiliated Hospital of Qingdao University","startDate":"2025-06-01","conditions":"Rectal Cancer Patients","enrollment":35},{"nctId":"NCT07252687","phase":"","title":"The Effect of Gender-affirmative Measures on Breast Perception in Trans Men","status":"RECRUITING","sponsor":"Medical University Innsbruck","startDate":"2025-11-30","conditions":"Transgender, Gender Dysphoria in Adolescents and Adults","enrollment":100},{"nctId":"NCT00936390","phase":"PHASE3","title":"Radiation Therapy With or Without Androgen-Deprivation Therapy in Treating Patients With Prostate Cancer","status":"COMPLETED","sponsor":"Radiation Therapy Oncology Group","startDate":"2009-09","conditions":"Prostate Cancer","enrollment":1538},{"nctId":"NCT01546987","phase":"PHASE3","title":"Hormone Therapy, Radiation Therapy, and Steroid 17alpha-monooxygenase TAK-700 in Treating Patients With High-Risk Prostate Cancer","status":"COMPLETED","sponsor":"Radiation Therapy Oncology Group","startDate":"2012-05","conditions":"Prostate Cancer","enrollment":239},{"nctId":"NCT07443826","phase":"PHASE1, PHASE2","title":"CALM-AF-AI: Counteracting Age-related Loss of Muscle With AAV-Follistatin Combined With Angiogenesis-Inducing VEGF Plasmid Gene Therapy","status":"RECRUITING","sponsor":"Unlimited Biotechnology LLC","startDate":"2026-03-31","conditions":"Age-related Muscle Decline","enrollment":12},{"nctId":"NCT05768711","phase":"PHASE2","title":"Azacitidine Combined With Venetoclax in Patients With Higher-risk Chronic Myelomonocytic Leukemia (AVENHIR)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Groupe Francophone des Myelodysplasies","startDate":"2023-10-04","conditions":"Chronic Myeloid Leukemia","enrollment":44},{"nctId":"NCT06510868","phase":"","title":"Evaluating Myelodysplastic Syndrome Risks in NET Patients Planned for Peptide Radionuclide Therapy","status":"RECRUITING","sponsor":"University Health Network, Toronto","startDate":"2024-08-01","conditions":"Myelodysplastic Syndrome, Acute Myeloid Leukemia","enrollment":45},{"nctId":"NCT07448974","phase":"PHASE3","title":"Vitamin D and Type 2 Diabetes - Treat-To-Target","status":"NOT_YET_RECRUITING","sponsor":"Tufts Medical Center","startDate":"2026-05","conditions":"Prediabetes, Type 2 Diabetes (T2DM)","enrollment":100},{"nctId":"NCT07217678","phase":"PHASE4","title":"Biomarkers of Ocular Surface Damage in the Setting of Topical Ocular Hypotensive Medication Use","status":"RECRUITING","sponsor":"University of Miami","startDate":"2026-02-09","conditions":"Glaucoma, Open-Angle Glaucoma, Ocular Hypertension","enrollment":20}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":46,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Duration of Treatment: 3 months","genericName":"Duration of Treatment: 3 months","companyName":"Organon and Co","companyId":"organon-and-co","modality":"Small molecule","firstApprovalDate":"","aiSummary":"This drug works by inhibiting the activity of a specific enzyme. Used for Treatment of endometriosis, Treatment of uterine fibroids.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}